AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...
Antech, a global veterinary diagnostics, technology and imaging company, today announced the launch of trūRapid™ FOUR, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results